Stock Price
68.58
Daily Change
-0.03 -0.04%
Monthly
0.69%
Yearly
-27.51%
Q2 Forecast
67.11

Merit Medical Systems reported $339.74M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
3M USD 3.26B 1.66B Mar/2026
Abbott USD 9.31B 104M Mar/2026
AngioDynamics USD 81.95M 1.68M Sep/2025
Anika Therapeutics USD 29.97M 116.84M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Globus Medical USD 645.11M 241.46M Dec/2025
Haemonetics USD 134.99M 1.26M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Olympus JPY 233.04B 18.77B Dec/2025
Pfizer USD 12.91B 79.89B Dec/2025
STAAR Surgical USD 68.74M 1.55M Dec/2025
Stryker USD 5.2B 505M Dec/2025
Surmodics USD 29.51M 274.86M Jun/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
Terumo JPY 252.74B 22.88B Dec/2025
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025